Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer (vol 6, pg 10604, 2015)

被引：0
|
作者：
Marin-Aguilera, Mercedes
Reig, Oscar
Lozano, Juan Jose
Jimenez, Natalia
Garcia-Recio, Susana
Erill, Nadina
Gaba, Lydia
Tagliapietra, Andrea
Ortega, Vanesa
Carrera, Gemma
Colomer, Anna
Gascon, Pedro
Mellado, Begona
机构：
来源：
ONCOTARGET | 2017年 / 8卷 / 16期
关键词：
D O I：
10.18632/oncotarget.17148
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：27673 / 27673
页数：1
相关论文
共 50 条
  • [31] Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer
    Scher, Howard I.
    Heller, Glenn
    Molina, Arturo
    Attard, Gerhardt
    Danila, Daniel C.
    Jia, Xiaoyu
    Peng, Weimin
    Sandhu, Shahneen K.
    Olmos, David
    Riisnaes, Ruth
    McCormack, Robert
    Burzykowski, Tomasz
    Kheoh, Thian
    Fleisher, Martin
    Buyse, Marc
    de Bono, Johann S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (12) : 1348 - +
  • [32] Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer
    Nagaya, Naoya
    Nagata, Masayoshi
    Lu, Yan
    Kanayama, Mayuko
    Hou, Qi
    Hotta, Zen-u
    China, Toshiyuki
    Kitamura, Kosuke
    Matsushita, Kazuhito
    Isotani, Shuji
    Muto, Satoru
    Sakamoto, Yoshiro
    Horie, Shigeo
    PLOS ONE, 2020, 15 (01):
  • [33] A Circulating Tumor Cell RNA Assay for Prognostication of Patients with Metastatic Castration-resistant Prostate Cancer
    Wang, Jasmine
    Kim, Minhyung
    Teng, Pai-Chi
    Jan, Yu Jen
    Chen, Jie-Fu
    Shi, Lucy Ruoxi
    You, Sungyong
    Tseng, Hsian-Rong
    Posadas, Edwin
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1568 - S1569
  • [34] Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer
    De Laere, Bram
    Oeyen, Steffi
    Van Oyen, Peter
    Ghysel, Christophe
    Ampe, Jozef
    Ost, Piet
    Demey, Wim
    Hoekx, Lucien
    Schrijvers, Dirk
    Brouwers, Barbara
    Lybaert, Willem
    Everaert, Els
    Van Kerckhove, Piet
    De Maeseneer, Daan
    Strijbos, Michiel
    Bols, Alain
    Fransis, Karen
    Beije, Nick
    de Kruijff, Inge
    van Dam, Valerie
    Brouwer, Anja
    van Dam, Pieter-Jan
    Van den Eynden, Gert
    Rutten, Annemie
    Sleijfer, Stefan
    Vandebroek, Jean
    Van Laere, Steven
    Dirix, Luc
    PROSTATE, 2018, 78 (06): : 435 - 445
  • [35] Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients
    Isebia, Khrystany T.
    Dathathri, Eshwari
    Verschoor, Noortje
    Nanou, Afroditi
    De Jong, Anouk C.
    Coumans, Frank A. W.
    Terstappen, Leon W. M. M.
    Kraan, Jaco
    Martens, John W. M.
    Bansal, Ruchi
    Lolkema, Martijn P.
    CANCERS, 2022, 14 (18)
  • [36] RNA SEQUENCING OF CIRCULATING TUMOR CELLS FROM MEN WITH CASTRATION-RESISTANT PROSTATE CANCER
    Nakazawa, Mary
    Lu, Changxue
    Chen, Yan
    Antonarakis, Emmanuel
    Luo, Jun
    JOURNAL OF UROLOGY, 2014, 191 (04): : E583 - E583
  • [37] Detection of Androgen Receptor Mutations in Circulating Tumor Cells in Castration-Resistant Prostate Cancer
    Jiang, Yuqiu
    Palma, John F.
    Agus, David B.
    Wang, Yixin
    Gross, Mitchell E.
    CLINICAL CHEMISTRY, 2010, 56 (09) : 1492 - 1495
  • [38] Dynamics of peripheral blood immune profiling associated with tumour progression in metastatic castration resistant prostate cancer (mCRPC)
    Perez Navarro, E.
    Conteduca, V.
    Gonzalez del Alba, A.
    Mellado, B.
    Cremaschi, P.
    Fernandez Calvo, O.
    Mendez Vidal, M. J.
    Climent Duran, M. A.
    Duran, I.
    Gallardo Diaz, E.
    Vazquez, S.
    Font Pous, A.
    Gurioli, G.
    Martinez, A.
    Lopez Andreo, M. J.
    Attard, G.
    Castellano Gauna, D.
    Grande, E.
    Giorgi, U.
    Gonzalez Billalabeitia, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S637 - S638
  • [39] Circulating Tumor Cells as a Biomarker of Survival and Response to Radium-223 Therapy: Experience in a Cohort of Patients With Metastatic Castration-Resistant Prostate Cancer
    Caries, Joan
    Castellano, Daniel
    Mendez-Vidal, Maria-Jose
    Mellado, Begona
    Saez, Maria-Isabel
    Gonzalez del Alba, Aranzazu
    Perez-Gracia, Jose-Luis
    Jimenez, Jose
    Suarez, Cristina
    Sepulveda, Juan M.
    Manneh, Ray
    Porras, Ignacio
    Lopez, Cristina
    Morales-Barrera, Rafael
    Arranz, Jose-Angel
    CLINICAL GENITOURINARY CANCER, 2018, 16 (06) : E1133 - E1139
  • [40] Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy
    Thalgott, M.
    Heck, M. M.
    Eiber, M.
    Souvatzoglou, M.
    Hatzichristodoulou, G.
    Kehl, V.
    Krause, B. J.
    Rack, B.
    Retz, M.
    Gschwend, J. E.
    Andergassen, U.
    Nawroth, R.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (08) : 1457 - 1464
12345